Published in Clin Microbiol Rev on October 01, 2000
Antimicrobial use and antimicrobial resistance: a population perspective. Emerg Infect Dis (2002) 3.07
Induction of gamma interferon and nitric oxide by truncated pneumolysin that lacks pore-forming activity. Infect Immun (2002) 1.00
Suboptimal antibiotic dosage as a risk factor for selection of penicillin-resistant Streptococcus pneumoniae: in vitro kinetic model. Antimicrob Agents Chemother (2003) 0.90
Comparison of the Denka Seiken slide agglutination method to the quellung test for serogrouping of Streptococcus pneumoniae isolates. J Clin Microbiol (2004) 0.87
Serogroup distribution and antimicrobial resistance of nasopharyngeal isolates of Streptococcus pneumoniae among Beijing children with upper respiratory infections (2000-2005). Eur J Clin Microbiol Infect Dis (2008) 0.85
Nasopharyngeal carriage rate of Streptococcus pneumoniae in Ugandan children with sickle cell disease. BMC Res Notes (2012) 0.82
Decrease in antibiotic use, an added benefit of PCVs. Lancet Infect Dis (2013) 0.75
Macrolide resistance in Streptococcus pneumoniae: Fallacy or fact? Can J Infect Dis (2002) 0.75
Antimicrobial Susceptibilities and Distribution of Resistance Genes for β-Lactams in Streptococcus pneumoniae Isolated in Hamadan. Jundishapur J Microbiol (2014) 0.75
Immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccine in Chinese healthy population aged >2 years: A randomized, double-blinded, active control, phase III trial. Hum Vaccin Immunother (2015) 0.75
[MRSA/MRSE-VISA/GISA/VRSA-PRP-VRE: current gram positive problem bacteria and mechanism of resistance, prevalence and clinical consequences]. Wien Med Wochenschr (2003) 0.75
Bacterial meningitis complicating the course of liver cirrhosis. Infection (2017) 0.75
Resistance, serotype and genetic diversity of Streptococcus pneumoniae-resistant strains isolated in the West Pomerania region of Poland in the years 2001-2005. Eur J Clin Microbiol Infect Dis (2008) 0.75
Discrepant serological assays for Pneumococcus in renal transplant recipients - a prospective study. Transpl Int (2017) 0.75
Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis (1998) 16.20
Detection of erythromycin-resistant determinants by PCR. Antimicrob Agents Chemother (1996) 10.56
Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network. N Engl J Med (1999) 10.06
Pneumococcal resistance to antibiotics. Clin Microbiol Rev (1990) 9.76
The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med (1997) 9.63
Nucleotide sequence of the Streptococcus faecalis plasmid gene encoding the 3'5"-aminoglycoside phosphotransferase type III. Gene (1983) 8.32
Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. J Infect Dis (1980) 7.45
Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (1997) 7.36
Acute otitis media: management and surveillance in an era of pneumococcal resistance--a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group. Pediatr Infect Dis J (1999) 5.88
Recombinational exchanges at the capsular polysaccharide biosynthetic locus lead to frequent serotype changes among natural isolates of Streptococcus pneumoniae. Mol Microbiol (1998) 5.12
The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proc Natl Acad Sci U S A (1999) 5.11
Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study. BMJ (1996) 4.80
Transposable multiple antibiotic resistance in Streptococcus pneumoniae. Mol Gen Genet (1986) 4.49
Nucleotide sequence of the tetM tetracycline resistance determinant of the streptococcal conjugative shuttle transposon Tn1545. Nucleic Acids Res (1986) 4.47
mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae. Antimicrob Agents Chemother (1997) 4.38
High-level fluoroquinolone resistance in Streptococcus pneumoniae requires mutations in parC and gyrA. Antimicrob Agents Chemother (1996) 4.04
Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae. JAMA (1998) 3.71
Pharmacokinetics and pharmacodynamics of antibiotics in otitis media. Pediatr Infect Dis J (1996) 3.59
Genetics of resistance to third-generation cephalosporins in clinical isolates of Streptococcus pneumoniae. Mol Microbiol (1992) 3.58
The population genetics of antibiotic resistance. Clin Infect Dis (1997) 3.51
A prospective study of the impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae. Clin Infect Dis (1997) 3.50
Evaluating treatment protocols to prevent antibiotic resistance. Proc Natl Acad Sci U S A (1997) 3.48
Emergence of vancomycin tolerance in Streptococcus pneumoniae. Nature (1999) 3.41
Resistant pneumococci: protecting patients through judicious use of antibiotics. Am Fam Physician (1997) 3.29
Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis (1997) 3.29
The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System. J Infect Dis (1996) 3.26
Decreasing antibiotic use in ambulatory practice: impact of a multidimensional intervention on the treatment of uncomplicated acute bronchitis in adults. JAMA (1999) 3.13
Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine. J Infect Dis (1996) 2.96
Carriage of pneumococci after pneumococcal vaccination. Lancet (1996) 2.69
Isolation and characterization of three Streptococcus pneumoniae transformation-specific loci by use of a lacZ reporter insertion vector. J Bacteriol (1998) 2.67
Vaccination against colonizing bacteria with multiple serotypes. Proc Natl Acad Sci U S A (1997) 2.58
Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997. Am J Public Health (2000) 2.57
A novel use of xylitol sugar in preventing acute otitis media. Pediatrics (1998) 2.52
Capsular transformation of a multidrug-resistant Streptococcus pneumoniae in vivo. J Infect Dis (1998) 2.33
Genetic relatedness within and between serotypes of Streptococcus pneumoniae from the United Kingdom: analysis of multilocus enzyme electrophoresis, pulsed-field gel electrophoresis, and antimicrobial resistance patterns. J Clin Microbiol (1996) 2.32
Risk factors for carriage of drug-resistant Streptococcus pneumoniae among children in Memphis, Tennessee. J Pediatr (1996) 2.17
Management of infections due to antibiotic-resistant Streptococcus pneumoniae. Clin Microbiol Rev (1998) 2.13
Impaired bacteriologic response to oral cephalosporins in acute otitis media caused by pneumococci with intermediate resistance to penicillin. Pediatr Infect Dis J (1996) 2.06
Penicillin-binding protein families: evidence for the clonal nature of penicillin resistance in clinical isolates of pneumococci. J Infect Dis (1989) 2.04
Genetic diversity of the streptococcal competence (com) gene locus. J Bacteriol (1999) 2.03
Antibiotic resistance in Streptococcus pneumoniae. Clin Infect Dis (1997) 2.01
Tn5253, the pneumococcal omega (cat tet) BM6001 element, is a composite structure of two conjugative transposons, Tn5251 and Tn5252. J Bacteriol (1991) 1.93
The transmission dynamics of antibiotic-resistant bacteria: the relationship between resistance in commensal organisms and antibiotic consumption. Proc Biol Sci (1997) 1.86
Streptococcus pneumoniae colonization in the young child: association with otitis media and resistance to penicillin. J Pediatr (1995) 1.84
Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid. Pediatr Infect Dis J (1997) 1.83
Minimizing the impact of drug-resistant Streptococcus pneumoniae (DRSP). A strategy from the DRSP Working Group. JAMA (1996) 1.79
Effect of antimicrobial use and other risk factors on antimicrobial resistance in pneumococci. Microb Drug Resist (1997) 1.70
The pneumococcal problem. BMJ (1996) 1.69
Major related sets of antibiotic-resistant Pneumococci in the United States as determined by pulsed-field gel electrophoresis and pbp1a-pbp2b-pbp2x-dhf restriction profiles. J Infect Dis (2000) 1.69
Antibiotic use in a periurban community in Mexico: a household and drugstore survey. Soc Sci Med (1996) 1.68
Mutations in the dihydrofolate reductase gene of trimethoprim-resistant isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother (1997) 1.66
Multiple colonization of the upper respiratory tract of Papua New Guinea children with Haemophilus influenzae and Streptococcus pneumoniae. Southeast Asian J Trop Med Public Health (1989) 1.59
Interaction of non-lytic beta-lactams with penicillin-binding proteins in Streptococcus pneumoniae. J Gen Microbiol (1987) 1.52
Xylitol chewing gum in prevention of acute otitis media: double blind randomised trial. BMJ (1996) 1.52
Combinational detection of autolysin and penicillin-binding protein 2B genes of Streptococcus pneumoniae by PCR. J Clin Microbiol (1996) 1.49
Antibiotic therapy in febrile children: "best-laid schemes". J Pediatr (1994) 1.44
Nasopharyngeal carriage of antibiotic-resistant pneumococci by children in group day care. J Infect Dis (1988) 1.42
Antibiotic use in a rural community in Bangladesh. Int J Epidemiol (1982) 1.37
Do intensive hospital antibiotic control programs prevent the spread of antibiotic resistance? Infect Control Hosp Epidemiol (1994) 1.37
Carriage of Haemophilus influenzae type b in children after widespread vaccination with conjugate Haemophilus influenzae type b vaccines. Pediatr Infect Dis J (1993) 1.36
The impact of HIV on Streptococcus pneumoniae bacteraemia in a South African population. AIDS (1998) 1.35
Increased carriage of trimethoprim/sulfamethoxazole-resistant Streptococcus pneumoniae in Malawian children after treatment for malaria with sulfadoxine/pyrimethamine. J Infect Dis (2000) 1.33
Risk factors and course of illness among children with invasive penicillin-resistant Streptococcus pneumoniae. The Streptococcus pneumoniae Working Group. Pediatrics (1999) 1.31
Purchase of antibiotics without prescription in Manila, the Philippines. Inappropriate choices and doses. J Clin Epidemiol (1990) 1.29
Nasopharyngeal colonization in southern Israel with antibiotic-resistant pneumococci during the first 2 years of life: relation to serotypes likely to be included in pneumococcal conjugate vaccines. J Infect Dis (1996) 1.27
Rapid detection of penicillin-resistant Streptococcus pneumoniae in cerebrospinal fluid by a seminested-PCR strategy. J Clin Microbiol (1998) 1.26
Dynamics of pneumococcal nasopharyngeal colonization during the first days of antibiotic treatment in pediatric patients. Pediatr Infect Dis J (1998) 1.22
Penicillin resistance and other predictors of mortality in pneumococcal bacteremia in a population with high human immunodeficiency virus seroprevalence. Clin Infect Dis (1999) 1.17
Identification of the tetracycline resistance gene, tet(O), in Streptococcus pneumoniae. Antimicrob Agents Chemother (1996) 1.16
A conservative amino acid mutation in the chromosome-encoded dihydrofolate reductase confers trimethoprim resistance in Streptococcus pneumoniae. J Infect Dis (1998) 1.16
Epidemiology of penicillin resistant pneumococci in Iceland. Microb Drug Resist (1995) 1.12
beta-lactam-resistant Streptococcus pneumoniae: epidemiology and evolutionary mechanism. Chemotherapy (1999) 1.12
Pilot trial of a pentavalent pneumococcal polysaccharide/protein conjugate vaccine in Gambian infants. Pediatr Infect Dis J (1996) 1.08
Choosing an antibiotic on the basis of pharmacodynamics. Ear Nose Throat J (1998) 1.07
Pneumococcal conjugate vaccines. Pediatr Infect Dis J (1999) 1.05
Nasopharyngeal colonization in Costa Rican children during the first year of life. Pediatr Infect Dis J (1997) 1.05
Shortened course of antibiotic therapy for acute otitis media, sinusitis and tonsillopharyngitis. Pediatr Infect Dis J (1997) 1.03
Change in nasopharyngeal carriage of Streptococcus pneumoniae resulting from antibiotic therapy for acute otitis media in children. Pediatr Infect Dis J (1997) 0.99
A multicenter, randomized, double-blind trial of 5 versus 10 days of antibiotic therapy for acute otitis media in young children. J Pediatr (1998) 0.96
Synergy between amoxicillin and gentamicin in combination against a highly penicillin-resistant and -tolerant strain of Streptococcus pneumoniae in a mouse pneumonia model. Antimicrob Agents Chemother (1996) 0.93
Impact of azithromycin on oropharyngeal carriage of group A Streptococcus and nasopharyngeal carriage of macrolide-resistant Streptococcus pneumoniae. Pediatr Infect Dis J (2000) 0.92
In-vitro development of resistance to beta-lactam antibiotics in Streptococcus pneumoniae. J Antimicrob Chemother (1995) 0.87
Application of pbp1A PCR in identification of penicillin-resistant Streptococcus pneumoniae. J Clin Microbiol (1999) 0.87
Two genes for chloramphenicol resistance common to staphylococci and streptococci. Eur J Epidemiol (1988) 0.82
Aminoglycosides are useful for severe respiratory tract infections. Semin Respir Infect (1997) 0.80
Experimental efficacy of combined ceftriaxone and amoxycillin on penicillin-resistant and broad-spectrum cephalosporin-resistant Streptococcus pneumoniae infection. J Antimicrob Chemother (1998) 0.80
Bacterial interference in the nasopharynx following antimicrobial therapy of acute otitis media. J Antimicrob Chemother (1998) 0.79
Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis (2000) 7.80
emm typing and validation of provisional M types for group A streptococci. Emerg Infect Dis (1999) 3.12
Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Arch Intern Med (2000) 3.09
Subcellular localization of proteins involved in the assembly of the spore coat of Bacillus subtilis. Genes Dev (1994) 2.69
Genetic locus for streptolysin S production by group A streptococcus. Infect Immun (2000) 2.52
Reducing antibiotic use in children: a randomized trial in 12 practices. Pediatrics (2001) 2.41
Role of the Escherichia coli O157:H7 O side chain in adherence and analysis of an rfb locus. Infect Immun (1996) 2.36
Antimicrobial use for pediatric upper respiratory infections: reported practice, actual practice, and parent beliefs. Pediatrics (1999) 2.34
Antimicrobial use in defined populations of infants and young children. Arch Pediatr Adolesc Med (2000) 2.01
Contrasting molecular epidemiology of group A streptococci causing tropical and nontropical infections of the skin and throat. J Infect Dis (2000) 1.90
Severe pneumococcal pneumonia in previously healthy children: the role of preceding influenza infection. Clin Infect Dis (2000) 1.89
Adverse and beneficial secondary effects of mass treatment with azithromycin to eliminate blindness due to trachoma in Nepal. Clin Infect Dis (2002) 1.84
Major related sets of antibiotic-resistant Pneumococci in the United States as determined by pulsed-field gel electrophoresis and pbp1a-pbp2b-pbp2x-dhf restriction profiles. J Infect Dis (2000) 1.69
Incidence of respiratory pathogens in persons hospitalized with pneumonia in two provinces in Thailand. Epidemiol Infect (2010) 1.65
Current attitudes regarding use of antimicrobial agents: results from physician's and parents' focus group discussions. Clin Pediatr (Phila) (1998) 1.55
Genetic linkage of exotoxin alleles and emm gene markers for tissue tropism in group A streptococci. J Infect Dis (1999) 1.52
A rapid pneumococcal serotyping system based on monoclonal antibodies and PCR. J Med Microbiol (2008) 1.48
Group A streptococcal genotypes from pediatric throat isolates in Rome, Italy. J Clin Microbiol (2001) 1.38
Invasive group A streptococcal disease in metropolitan Atlanta: a population-based assessment. Clin Infect Dis (1998) 1.36
Epidemiologic analysis of invasive and noninvasive group a streptococcal isolates in Hong Kong. J Clin Microbiol (2003) 1.34
Increased carriage of trimethoprim/sulfamethoxazole-resistant Streptococcus pneumoniae in Malawian children after treatment for malaria with sulfadoxine/pyrimethamine. J Infect Dis (2000) 1.33
A genetic-based evaluation of the principal tissue reservoir for group A streptococci isolated from normally sterile sites. J Infect Dis (1997) 1.32
Genotypic survey of recent beta-lactam-resistant pneumococcal nasopharyngeal isolates from asymptomatic children in Chile. J Clin Microbiol (1999) 1.14
Vitamin A therapy for children with respiratory syncytial virus infection: a multicenter trial in the United States. Pediatr Infect Dis J (1996) 1.13
Epidemiologic applications of novel molecular methods to detect and differentiate small round structured viruses (Norwalk-like viruses). J Med Virol (1995) 1.12
Dengue fever: a resurgent risk for the international traveler. Am Fam Physician (1992) 1.06
New emm (M protein gene) sequences of group A streptococci isolated from Malaysian patients. Emerg Infect Dis (1999) 1.04
Genetic suppression analysis of sigma E interaction with three promoters in sporulating Bacillus subtilis. Gene (1992) 1.03
Anomalies in emm typing of group A streptococci. Adv Exp Med Biol (1997) 1.00
Genetic and phenotypic features of Streptococcus pyogenes strains isolated in Brazil that harbor new emm sequences. J Clin Microbiol (2001) 1.00
Disruption of tonB in Bordetella bronchiseptica and Bordetella pertussis prevents utilization of ferric siderophores, haemin and haemoglobin as iron sources. Microbiology (1999) 0.99
Respiratory syncytial virus: not just for kids. Hosp Pract (1995) (1997) 0.98
An outbreak of skin sepsis in abattoir workers caused by an 'unusual' strain of Streptococcus pyogenes. J Med Microbiol (2000) 0.93
Haemophilus influenzae type b and Streptococcus pneumoniae as causes of pneumonia among children in Beijing, China. Emerg Infect Dis (2000) 0.92
Impact of azithromycin on oropharyngeal carriage of group A Streptococcus and nasopharyngeal carriage of macrolide-resistant Streptococcus pneumoniae. Pediatr Infect Dis J (2000) 0.92
Optimizing culture of Chlamydia pneumoniae by using multiple centrifugations. J Clin Microbiol (1999) 0.92
Epidemiology of emerging pneumococcal drug resistance: implications for treatment and prevention. Vaccine (1998) 0.92
Analysis of immunoreactivity to a Streptococcus equi subsp. zooepidemicus M-like protein To confirm an outbreak of poststreptococcal glomerulonephritis, and sequences of M-like proteins from isolates obtained from different host species. J Clin Microbiol (2000) 0.91
FtsZ and cell division. Res Microbiol (1991) 0.86
Necrotizing fasciitis due to penicillin-resistant Streptococcus pneumoniae: case report and review of the literature. J Infect (2001) 0.84
Pharyngeal colonization with Haemophilus influenzae type b in children in a day care center without invasive disease. J Pediatr (1985) 0.83
Duration of the melatonin pulse in the hypothalamus controls testicular function in pinealectomized mice (Peromyscus leucopus). Biol Reprod (1987) 0.81
Lack of association between Kawasaki syndrome and Chlamydia pneumoniae infection: an investigation of a Kawasaki syndrome cluster in San Diego County. Pediatr Infect Dis J (2000) 0.80
Streptococcus pyogenes emm and T types within a decade, 1996-2005: implications for epidemiology and future vaccines. Epidemiol Infect (2009) 0.80
Physician control of pediatric antimicrobial use in Beijing, China, and its rural environs. Pediatr Infect Dis J (2001) 0.79
The best treatment for pneumonia: new clues, but no definitive answers. Arch Intern Med (1999) 0.78
Prevalence of human parvovirus B19 infection in children with Henoch-Schönlein purpura. Arthritis Rheum (1996) 0.76
Treating cardiovascular disease with antimicrobial agents: a survey of knowledge, attitudes, and practices among physicians in the United States. Clin Infect Dis (2001) 0.75
New multilocus sequence types of Streptococcus pneumoniae isolates from patients with respiratory infections in India. Indian J Med Res (2007) 0.75
Low attack rate of summertime influenza: could it be the host? Clin Infect Dis (2001) 0.75
Evaluation of synthetic, M type-specific peptides as antigens in a multivalent group A streptococcal vaccine. Vaccine (2003) 0.75
Acute otitis media caused by resistant pneumococci. Am Fam Physician (2000) 0.75
Acute otitis media: management and surveillance in an era of pneumococcal resistance. Drug-Resistant Streptococcus Pneumoniae Therapeutic Working Group. Nurse Pract (1999) 0.75
HTLV-I and HIV-1-associated neurologic abnormalities; syphilis as a confounding factor. AIDS (1989) 0.75